Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Radium-223 in mCRPC: Where are we at in 2021?

Radium-223 in mCRPC: Where are we at in 2021?

Find a Physician

FIND A PHYSICIAN

Quickly search our world-class physicians and faculty by keyword, location and insurance provider.

Search

At the 2021 New York GU 14th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Scott T. Tagawa, MD, discussed the latest developments with the alpha particle–emitting radioactive therapeutic agent radium-223 (Xofigo) in patients with castration-resistant prostate cancer (CRPC) and bone metastases.  Read More

Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.